<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">6q9FS73LLrZcwLPjktzFNSv</article-id>
      <article-id pub-id-type="other">00010</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2009000900010</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(09)09300310</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2009000900010</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>&#205;ndice de massa corporal apresenta boa correla&#231;&#227;o com o perfil pr&#243;-ateroscler&#243;tico em crian&#231;as e adolescentes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Geodete Batista</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Horta</surname>
            <given-names>Naira</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Resende</surname>
            <given-names>Zulmira Freire</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Graziela</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barreto</surname>
            <given-names>Larissa Machado de Farias</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Correia</surname>
            <given-names>Luis Henrique</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nascimento</surname>
            <given-names>Thiago Augusto</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rios</surname>
            <given-names>Clay Barreto</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barreto-Filho</surname>
            <given-names>Jos&#233; Augusto</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lopes</surname>
            <given-names>Heno Ferreira</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="state">Sergipe</named-content>
        </addr-line>
        <institution content-type="orgname">Unidade Cardiotor&#225;cica de Sergipe</institution>
        <country country="BR">Brasil</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Instituto do Cora&#231;&#227;o</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="state">Sergipe</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de Sergipe</institution>
        <institution content-type="orgdiv1">Hospital Escola </institution>
        <country country="BR">Brasil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>09</month>
        <year>2009</year>
      </pub-date>
      <volume>93</volume>
      <issue>3</issue>
      <fpage>261</fpage>
      <lpage>267</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>08</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>10</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>02</day>
          <month>10</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: Recentemente, uma associa&#231;&#227;o de diferentes fatores de risco foi descrita como a s&#237;ndrome metab&#243;lica. Diferentes defini&#231;&#245;es est&#227;o sendo utilizadas para a mesma s&#237;ndrome. Independente do nome ou da classifica&#231;&#227;o, estabeleceu-se que um agrupamento de fatores de risco cardiovasculares incluindo sobrepeso/obesidade, aumento da press&#227;o arterial e anormalidade lip&#237;dicas e glic&#234;micas est&#225; associado com aumento do risco de aterosclerose em adultos. OBJETIVO: O objetivo desse estudo foi correlacionar os percentis do &#237;ndice de massa corporal com a press&#227;o arterial (PA), &#237;ndice de resist&#234;ncia &#224; insulina (HOMA-ir) e perfis lip&#237;dicos em crian&#231;as e adolescentes, os quais caracterizam um perfil pr&#243;-ateroscler&#243;tico. M&#201;TODOS: Agrupamentos de fatores de risco cardiovasculares foram avaliados em 118 crian&#231;as e adolescentes, divididos de acordo com os quartis do percentil de &#237;ndice de massa corporal (PIMC): Q1 (n=23) com PIMC &lt;50%, Q2 (n=30) com PIMC entre 50 e 85%, Q3 (n=31) com PIMC entre 85 e 93%, e Q4 (n=34) com PIMC &gt; 93%. Estatisticamente, diferen&#231;as significantes n&#227;o foram observadas para idade (F=2,1; p=0,10); sexo (teste Qui-quadrado=3,0; p=0,38), e etnia (teste do Qui-quadrado = 4,7; p=0,20) entre diferentes quartis. RESULTADOS: Uma diferen&#231;a estatisticamente significante foi observada para PA sist&#243;lica (F=15,4; p&lt;0,0001), PA diast&#243;lica (F=9,5; p&lt;0,0001), glicemia (F=9,6; p&lt;0,0001), insulina (F=12.9; p&lt;0.0001), HOMA-ir (F=30,8; p&lt;0,0001), e n&#237;veis de triglic&#233;rides (F=2,7; p=0,05) entre os diferentes quartis. CONCLUS&#195;O: O excesso de peso avaliado pelo PIMC foi associado ao aumento de PA, triglic&#233;rides, &#237;ndice HOMA-ir, e HDL - colesterol baixo, o que configura um perfil pr&#243;-ateroscler&#243;tico em crian&#231;as e adolescentes.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>&#205;ndice de massa corporal</kwd>
        <kwd>crian&#231;a</kwd>
        <kwd>adolescente</kwd>
        <kwd>fatores de risco</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>22</day>
        <month>10</month>
        <year>2009</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> HIPERTENS&#195;O ARTERIAL SIST&#202;MICA</p>
    <p>&#205;ndice de massa corporal apresenta boa correla&#231;&#227;o com o perfil pr&#243;-ateroscler&#243;tico em crian&#231;as e adolescentes</p>
    <p>
      <bold>Geodete Batista Costa<sup>II, III</sup>; Naira Horta<sup>III</sup>; Zulmira Freire Resende<sup>III</sup>; Graziela Souza<sup>III</sup>; Larissa Machado de Farias Barreto<sup>III</sup>; Luis Henrique Correia<sup>III</sup>; Thiago Augusto Nascimento<sup>III</sup>; Clay Barreto Rios<sup>III</sup>; Jos&#233; Augusto Barreto-Filho<sup>III</sup>; Heno Ferreira Lopes<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Instituto do Cora&#231;&#227;o (InCor), Faculdade de Medicina da Universidade de S&#227;o Paulo </p>
    <p><sup>II</sup>Hospital Escola da Universidade de Sergipe, Sergipe; Brasil </p>
    <p><sup>III</sup>Unidade Cardiotor&#225;cica de Sergipe, Sergipe, Brasil </p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> Recentemente, uma associa&#231;&#227;o de diferentes fatores de risco foi descrita como a s&#237;ndrome metab&#243;lica. Diferentes defini&#231;&#245;es est&#227;o sendo utilizadas para a mesma s&#237;ndrome. Independente do nome ou da classifica&#231;&#227;o, estabeleceu-se que um agrupamento de fatores de risco cardiovasculares incluindo sobrepeso/obesidade, aumento da press&#227;o arterial e anormalidade lip&#237;dicas e glic&#234;micas est&#225; associado com aumento do risco de aterosclerose em adultos. </p>
    <p><bold>OBJETIVO:</bold> O objetivo desse estudo foi correlacionar os percentis do &#237;ndice de massa corporal com a press&#227;o arterial (PA), &#237;ndice de resist&#234;ncia &#224; insulina (HOMA-ir) e perfis lip&#237;dicos em crian&#231;as e adolescentes, os quais caracterizam um perfil pr&#243;-ateroscler&#243;tico. </p>
    <p><bold>M&#201;TODOS:</bold> Agrupamentos de fatores de risco cardiovasculares foram avaliados em 118 crian&#231;as e adolescentes, divididos de acordo com os quartis do percentil de &#237;ndice de massa corporal (PIMC): Q1 (n=23) com PIMC &lt;50%, Q2 (n=30) com PIMC entre 50 e 85%, Q3 (n=31) com PIMC entre 85 e 93%, e Q4 (n=34) com PIMC &gt; 93%. Estatisticamente, diferen&#231;as significantes n&#227;o foram observadas para idade (F=2,1; p=0,10); sexo (teste Qui-quadrado=3,0; p=0,38), e etnia (teste do Qui-quadrado = 4,7; p=0,20) entre diferentes quartis. </p>
    <p><bold>RESULTADOS:</bold> Uma diferen&#231;a estatisticamente significante foi observada para PA sist&#243;lica (F=15,4; p&lt;0,0001), PA diast&#243;lica (F=9,5; p&lt;0,0001), glicemia (F=9,6; p&lt;0,0001), insulina (F=12.9; p&lt;0.0001), HOMA-ir (F=30,8; p&lt;0,0001), e n&#237;veis de triglic&#233;rides (F=2,7; p=0,05) entre os diferentes quartis. </p>
    <p><bold>CONCLUS&#195;O:</bold> O excesso de peso avaliado pelo PIMC foi associado ao aumento de PA, triglic&#233;rides, &#237;ndice HOMA-ir, e HDL &#150; colesterol baixo, o que configura um perfil pr&#243;-ateroscler&#243;tico em crian&#231;as e adolescentes. </p>
    <p><bold>Palavras chave:</bold> &#205;ndice de massa corporal, crian&#231;a, adolescente, fatores de risco.</p>
    <p>
      <bold>Abrevia&#231;&#245;es</bold>
    </p>
    <p>PIMC - percentil do &#237;ndice de massa corporal </p>
    <p>PA &#150; press&#227;o arterial</p>
    <p>HDL &#150; lipoprote&#237;na de alta densidade</p>
    <p>HOMA-ir - Modelo de Avalia&#231;&#227;o da Homeostase da resist&#234;ncia &#224; insulina </p>
    <p>LDL &#150; lipoprote&#237;na de baixa densidade </p>
    <p>SM &#150; s&#237;ndrome metab&#243;lica </p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>De acordo com a Organiza&#231;&#227;o Mundial da Sa&#250;de (OMS)<sup>1</sup>, a obesidade est&#225; assumindo propor&#231;&#245;es epid&#234;micas em todo o mundo e &#233; considerada uma doen&#231;a pedi&#225;trica cr&#244;nica, mais perigosa que a desnutri&#231;&#227;o, pelo fato de estar associada com um grande n&#250;mero de comorbidades. Os problemas associados com a obesidade incluem problemas psicossociais (baixa auto-estima, afetando a capacidade acad&#234;mica e relacionamentos), problemas sociais (preconceito) e culminam na associa&#231;&#227;o de obesidade central, resist&#234;ncia &#224; insulina, hipertens&#227;o e dislipidemia, que caracterizam um agrupamento de fatores de risco cardiovasculares, tamb&#233;m chamados de s&#237;ndrome metab&#243;lica (SM). A s&#237;ndrome metab&#243;lica est&#225; associada com um aumento na probabilidade de doen&#231;a ateroscler&#243;tica, esteato-hepatite e calculose biliar, a qual est&#225; presente em indiv&#237;duos sedent&#225;rios com nutri&#231;&#227;o exagerada e predisposi&#231;&#227;o gen&#233;tica<sup>2</sup>. </p>
    <p>A preval&#234;ncia dessa situa&#231;&#227;o est&#225; aumentando em crian&#231;as e adolescentes e o diabetes do tipo 2 est&#225; aparecendo nessa popula&#231;&#227;o com maior frequ&#234;ncia<sup>3</sup>. H&#225; outras situa&#231;&#245;es cl&#237;nicas associadas com esse agrupamento de fatores de risco cardiovasculares que requerem aten&#231;&#227;o: apn&#233;ia do sono associada &#224; hipertens&#227;o pulmonar, hipertrofia do ventr&#237;culo esquerdo, pseudotumor cerebral e dist&#250;rbios ortop&#233;dicos<sup>4</sup>. Evid&#234;ncias cient&#237;ficas t&#234;m revelado que a hipertens&#227;o arterial e a aterosclerose t&#234;m in&#237;cio na inf&#226;ncia, quando os h&#225;bitos relacionados &#224; atividade f&#237;sica e nutri&#231;&#227;o s&#227;o formados<sup>5</sup>. </p>
    <p>Este estudo descreve o impacto do excesso de peso, avaliado atrav&#233;s do percentil do &#237;ndice de massa corporal (PIMC) e fornece os resultados dos n&#237;veis de PA, &#237;ndice de resist&#234;ncia &#224; insulina e perfil lip&#237;dico em crian&#231;as e adolescentes considerados clinicamente normais. </p>
    <p>Nossa hip&#243;tese &#233; que o aumento no PIMC resulta em uma maior probabilidade de agrupamento de fatores de risco cardiovasculares, independente da idade e das caracter&#237;sticas cl&#237;nicas.</p>
    <p>
      <bold>Pacientes</bold>
    </p>
    <p>Este &#233; um estudo cl&#237;nico controlado (estudo anal&#237;tico transversal), que correlaciona o percentil do &#237;ndice de massa corporal (PIMC) com o perfil cardiovascular e bioqu&#237;mico em uma popula&#231;&#227;o de crian&#231;as e adolescentes recrutados sequencialmente entre Janeiro e Novembro de 2005 em cl&#237;nicas cardio-pedi&#225;tricas, endocrinol&#243;gicas, centros ambulatoriais e cl&#237;nicas particulares. Um total de 118 indiv&#237;duos foi inclu&#237;do no estudo. Eles foram divididos em quartis de acordo com o percentil do &#237;ndice de massa corporal (PIMC): Q1 (n = 23) com PIMC &lt;50%; Q2 (n=30) com PIMC entre 50 e 85%; Q3 (n=31) com PIMC entre 85 e 93%, e finalmente, Q4 (n=34) com PIMC &gt;93%. As caracter&#237;sticas cl&#237;nicas da popula&#231;&#227;o s&#227;o mostradas na <xref ref-type="table" rid="tab01">Tabela 1</xref>. </p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gt01.jpg"/></table-wrap>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Todas as medidas antropom&#233;tricas foram realizadas no in&#237;cio da manh&#227; e os volunt&#225;rios estavam em jejum: a) O peso foi medido em uma balan&#231;a digital Tech Line, modelo Tec 10L (Techline Asia, China). Todos os indiv&#237;duos usavam roupas leves, estavam descal&#231;os e na posi&#231;&#227;o ortost&#225;tica. b) A altura foi medida atrav&#233;s de um estadi&#244;metro fixado na posi&#231;&#227;o vertical. Os indiv&#237;duos eram colocados na posi&#231;&#227;o ortost&#225;tica, descal&#231;os, com as pernas juntas e as n&#225;degas e ombros em contato com o eixo vertical do estadi&#244;metro. Os bra&#231;os eram mantidos pr&#243;ximos ao corpo e a medida era tomada no final da expira&#231;&#227;o. O peso e a altura foram registrados de acordo com as curvas de Tanner<sup>6</sup>. c) O &#205;ndice de Massa Corporal (IMC) ou &#205;ndice Quetelet = peso (kg) dividido pela altura (m<sup>2</sup>) foi calculado. Como essa &#233; uma popula&#231;&#227;o de crian&#231;as e adolescentes, o percentil para o IMC foi usado de acordo com o National Center for Health Statistics<sup>7</sup> e aplicado para agrup&#225;-los em diferentes quartis.</p>
    <p>A press&#227;o arterial (PA) foi medida de acordo com o protocolo recomendado pelo Update on the Task Force Report (1987) on High Blood Pressure in Children and Adolescents: A Working Group Report from the High Blood Pressure Education Program<sup>8</sup>. Um esfigmoman&#244;metro de merc&#250;rio calibrado, com manguito adequado, foi utilizado para medir a PA. Os indiv&#237;duos permaneceram na posi&#231;&#227;o sentada por pelo menos 10 minutos em condi&#231;&#245;es de descanso. A Fase I de Korotkoff foi adotada para definir a press&#227;o arterial sist&#243;lica e a Fase V de Korotkoff para press&#227;o arterial diast&#243;lica. Houve um intervalo de 2 minutos entre as medidas. Os indiv&#237;duos foram instru&#237;dos a n&#227;o ingerir caf&#233;, ch&#225;, anti-inflamat&#243;rios n&#227;o-ester&#243;ides, corticoster&#243;ides e vasoconstritores nasais por 12 horas antes da medida de press&#227;o arterial. A m&#233;dia de tr&#234;s medidas consecutivas foi utilizada, Para ambos os sexos, a PA foi corrigida de acordo com o percentil da altura. </p>
    <p>Para a an&#225;lise bioqu&#237;mica, amostras de sangue foram colhidas ap&#243;s um per&#237;odo de jejum de 12 horas. O plasma foi separado e armazenado a -10&#186; C em um freezer. O n&#237;vel de triglic&#233;rides foi determinado pelo m&#233;todo enzim&#225;tico Trinder-reagente Labtest &#150; colorim&#233;trico (kit comercial). O HDL - colesterol foi determinado atrav&#233;s do m&#233;todo COD-ANA Labtest Cat &#150; 60 (kit comercial). A glicemia de jejum foi determinada pelo m&#233;todo colorim&#233;trico enzim&#225;tico - Glucox 500/glicose oxidase (Selectra II, Brasil). A insulina foi medida pelo m&#233;todo de quimiluminesc&#234;ncia, usando um equipamento Immulite 2000 (DPC, EUA). A glicemia de jejum e a insulina foram utilizados para calcular o &#205;ndice do Modelo de Avalia&#231;&#227;o da Homeostase da Resist&#234;ncia &#224; Insulina (HOMA-ir) (glicose mg/dl x insulina <italic>&#181;</italic>U/ml/22,5)<sup>9</sup>. Os pais ou tutores de todos os pacientes inclu&#237;dos no estudo assinaram o termo de consentimento livre e informado. O Comit&#234; de &#201;tica da Universidade Federal de Sergipe, Brasil, aprovou esta pesquisa. </p>
    <p>
      <bold>An&#225;lise Estat&#237;stica</bold>
    </p>
    <p>O software SPSS vers&#227;o 13.0 (SPSS, Chicago, IL) foi utilizado na an&#225;lise estat&#237;stica. Dados n&#227;o-num&#233;ricos foram resumidos em propor&#231;&#245;es, com os respectivos intervalos de confian&#231;a de 95%. Os dados num&#233;ricos s&#227;o mostrados em m&#233;dias e desvios-padr&#227;o. Vari&#225;veis nominais s&#227;o mostradas em frequ&#234;ncias. A distribui&#231;&#227;o normal foi testada atrav&#233;s do m&#233;todo de Shapiro-Wilkis. A an&#225;lise de vari&#226;ncia (ANOVA) foi utilizada para analisar a varia&#231;&#227;o das vari&#225;veis associadas com a s&#237;ndrome metab&#243;lica de acordo com o percentil do &#237;ndice de massa corporal (PIMC). One-way ANOVA foi utilizada para comparar diferentes quartis do PIMC; Bonferroni (vari&#226;ncia igual) e Tamhne (vari&#226;ncia diferente) foram usados como p&#243;s-testes. A an&#225;lise de tend&#234;ncia e a avalia&#231;&#227;o de tend&#234;ncias lineares, c&#250;bicas e quadr&#225;ticas para diferentes fatores em cada quartil foram medidas pelo m&#233;todo polinomial. O valor de P&lt;0,05 foi adotado como estatisticamente significante. </p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>A popula&#231;&#227;o n&#227;o diferiu em m&#233;dia de idade (F=2,1; p=0,10); distribui&#231;&#227;o de sexo (teste do Qui-quadrado =3,04; p=0,38), e etnia (teste de Qui-quadrado = 4,7; p=0,20) entre os diferentes quartis (<xref ref-type="table" rid="tab01">Tabela 1</xref>). </p>
    <p>Houve uma diferen&#231;a estatisticamente significante em rela&#231;&#227;o &#224; PA sist&#243;lica entre os diferentes quartis (F=15,4; p&lt;0,0001): Q4 <italic>versus</italic> Q1 (32,8&#177;4,1; p&lt;0,0001); Q4 <italic>versus</italic> Q2 (23,0&#177;4,0; p&lt;0,0001); Q3 <italic>versus</italic> Q1 (13,5&#177;3,9; p=0,002); Q3 <italic>versus</italic> Q2 (12,2&#177;4,0; p=0,02). N&#227;o houve diferen&#231;a entre Q1 e Q2 (<xref ref-type="fig" rid="fig01">Figura 1</xref>). Uma diferen&#231;a estatisticamente significante foi observada para PA diast&#243;lica entre os quartis (F=9,5; p&lt;0,0001): Q4 <italic>versus</italic> Q1 (12,9&#177;2,7; p&lt;0,01); Q4 <italic>versus</italic> Q2 (10,8&#177;2,5; p&lt;0,0002) e Q4 <italic>versus</italic> Q3 (7,0&#177;2,5; p=0,04) (<xref ref-type="fig" rid="fig02">Figura 2</xref>).</p>
    <fig id="fig01">
      <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf01.jpg"/></fig>
    <fig id="fig02">
      <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf02.jpg"/></fig>
    <p>Em rela&#231;&#227;o ao metabolismo de carboidratos, uma diferen&#231;a estatisticamente significante foi observada entre os diferentes quartis para a glicemia (F=9,6; p&lt;0,0001); insulina (F=12,9; p&lt;0,0001), e HOMA-ir (F=30,8; p&lt;0,0001). Para a glicemia, uma diferen&#231;a foi observada entre os quartis: Q4 <italic>versus</italic> Q1 (12,2&#177;2,6; p&lt;0,001); Q4 <italic>versus</italic> Q2 (10,3&#177;2,4; p=0,0002), e Q4 <italic>versus</italic> Q3 (7,2&#177;2,4; p=0,02) (<xref ref-type="fig" rid="fig03">Figura 3</xref>). Uma diferen&#231;a estatisticamente significante foi observada para a insulina entre os quartis: Q4 <italic>versus</italic> Q1 (7,4&#177;1,4; p&lt;0,0001); Q4 <italic>versus</italic> Q2 (6,9&#177;1,4; p&lt;0,0001); Q3 <italic>versus</italic> Q1 (3,5&#177;1,1; p=0,01), e Q3 <italic>versus</italic> Q2 (3,0&#177;1,1; p=0,01) (<xref ref-type="fig" rid="fig04">Figura 4</xref>). O &#237;ndice HOMA-ir diferiu significantemente entre os quartis: Q4 <italic>versus</italic> Q1 (46,3&#177;6,0; p&lt;0,0001); Q4 <italic>versus</italic> Q2 (45,6&#177;6,0; p&lt;0,0001); Q4 <italic>versus</italic> Q3 (21,5&#177;7,2; p=0,02); Q3 <italic>versus</italic> Q1 (24,8&#177;3,9; p&lt;0,0001) e Q3 <italic>versus</italic> Q2 (24,2&#177;3,9; p&lt;0,0001) (<xref ref-type="fig" rid="fig05">Figura 5</xref>).</p>
    <fig id="fig03">
      <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf03.jpg"/></fig>
    <fig id="fig04">
      <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf04.jpg"/></fig>
    <fig id="fig05">
      <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf05.jpg"/></fig>
    <p>Uma diferen&#231;a estatisticamente significante foi observada nos perfis lip&#237;dicos entre os quartis Q4 <italic>versus</italic> Q1 (38,6&#177;13,3; p=0,03) para triglic&#233;rides (F=2,7; p=0,05) (<xref ref-type="fig" rid="fig06">Figura 6</xref>). Uma redu&#231;&#227;o nos n&#237;veis de HDL - colesterol foi observada entre quartis; entretanto, essa diferen&#231;a n&#227;o foi estatisticamente significante (F=1,9; p=0,14) (<xref ref-type="fig" rid="fig07">Figura 7</xref>). Uma an&#225;lise de tend&#234;ncias foi executada e um aumento linear e significante foi observado para a PA sist&#243;lica (F=39,3; p&lt;0,0001); PA diast&#243;lica (F=24,7; p&lt;0,0001); glicemia (F=26,5; p&lt;0,0001); insulina (F=32,5; p&lt;0,0001); triglic&#233;rides (F=7,9; p=0,006), e HDL - colesterol (F=5,3; p=0,03), entre os quartis. Uma tend&#234;ncia tamb&#233;m foi observada na varia&#231;&#227;o quadr&#225;tica para o &#237;ndice HOMA-ir (F=6,5; p=0,01), entre os quartis.</p>
    <fig id="fig06">
      <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf06.jpg"/></fig>
    <fig id="fig07">
      <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf07.jpg"/></fig>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>H&#225; v&#225;rios estudos relacionados a fatores de risco cardiovasculares em adultos. Entretanto, h&#225; poucos estudos relacionados ao agrupamento de fatores de risco cardiovasculares em crian&#231;as e adolescentes. Entre os estudos que j&#225; avaliaram os fatores de risco cardiovasculares associados em crian&#231;as e adolescentes, est&#227;o o Bogalusa Heart Study<sup>10</sup>, o Muscatine Study<sup>11</sup>, e o PDAY<sup>12</sup>. Esses estudos mostram a associa&#231;&#227;o entre m&#250;ltiplos fatores de risco e aterosclerose em crian&#231;as e jovens adultos. Em nosso estudo, observamos a associa&#231;&#227;o entre o PIMC e um agrupamento de fatores de risco cardiovasculares, tais como aumento da press&#227;o arterial, HDL-colesterol baixo, aumento dos n&#237;veis de triglic&#233;rides, aumento dos n&#237;veis de glicemia e insulina e aumento da resist&#234;ncia &#224; insulina avaliada atrav&#233;s do &#237;ndice HOMA-ir em crian&#231;as e adolescentes. Sabe-se que esse agrupamento de fatores de risco cardiovasculares que aparece no in&#237;cio da vida ir&#225; persistir e piorar se a preven&#231;&#227;o prim&#225;ria n&#227;o for adotada precocemente. Consequentemente, esse agrupamento de fatores de risco cardiovasculares ir&#225; resultar em morbidade e mortalidade cardiovasculares em jovens adultos. A antropometria &#233; considerada um m&#233;todo &#250;til para identificar excesso de peso, pois &#233; um m&#233;todo acess&#237;vel e aplic&#225;vel universalmente. </p>
    <p>Os &#237;ndices antropom&#233;tricos s&#227;o obtidos a partir de duas ou mais combina&#231;&#245;es b&#225;sicas (peso, sexo, idade e altura)<sup>1</sup>. O IMC &#233; calculado de acordo com o peso e altura e &#233; amplamente utilizado e aceito para identificar indiv&#237;duos com sobrepeso e obesos. Mas o uso do IMC para crian&#231;as e adolescentes come&#231;ou ap&#243;s o estudo de Must e cols.<sup>13</sup>, o qual relatou valores de referencia para percentis de acordo com a idade e o sexo, e estes s&#227;o atualmente considerados os valores de referencia pela OMS. De acordo com este estudo, indiv&#237;duos com percentis de IMC <underline>&gt;</underline>85 e &lt;95 s&#227;o considerados como tendo sobrepeso e indiv&#237;duos com percentis de IMC <underline>&gt;</underline>95 s&#227;o considerados obesos. Embora o IMC tenha sido usado para caracterizar obesidade em crian&#231;as e adolescentes, ele apresenta limita&#231;&#245;es. Uma limita&#231;&#227;o apontada por Luukkaa e cols.<sup>14</sup> &#233; que o IMC n&#227;o diferencia a massa magra da massa gorda e n&#227;o permite a separa&#231;&#227;o de indiv&#237;duos com aumento de massa muscular daqueles com aumento de massa gorda. Entretanto, mesmo o quartil inferior (Q1) da distribui&#231;&#227;o da prega cut&#226;nea subescapular, comparado ao quartil superior (Q4), est&#225; relacionado ao aumento do risco de n&#237;veis elevados de colesterol total em crian&#231;as e adolescentes<sup>15</sup>. </p>
    <p>Atualmente, &#233; importante conhecer n&#227;o apenas a massa gorda, mas tamb&#233;m a distribui&#231;&#227;o da gordura. Em rela&#231;&#227;o &#224; distribui&#231;&#227;o da gordura, Fujioka e cols.<sup>16</sup> mostraram que a gordura abdominal est&#225; associada com um alto risco de morbidade e mortalidade, principalmente devido a doen&#231;a cardiovascular. Lapidus e cols.<sup>17</sup> demonstraram que o aumento da gordura abdominal est&#225; associada com aumento dos n&#237;veis de insulina no plasma (hiperinsulinemia) e esse aumento &#233; preditivo de hipertens&#227;o e dislipidemia futuras. Em outro estudo<sup>18</sup>, os autores conclu&#237;ram que a gordura abdominal &#233; um importante preditor de um aumento dos n&#237;veis de triglic&#233;rides, uma diminui&#231;&#227;o nos n&#237;veis de HDL-colesterol, e um aumento da massa ventricular esquerda em crian&#231;as e adolescentes. </p>
    <p>Sabe-se que a PA sist&#243;lica aumenta progressivamente a partir de 1 ano de idade at&#233; a adolesc&#234;ncia e que a PA diast&#243;lica aumenta ap&#243;s 5 ou 6 anos de idade, proporcionalmente &#224; PA sist&#243;lica. Em crian&#231;as pequenas, a hipertens&#227;o secund&#225;ria &#233; mais frequente e ap&#243;s os 10 anos de idade, principalmente no adolescente, &#233; a forma prim&#225;ria da hipertens&#227;o a mais observada<sup>19</sup>. Em uma revis&#227;o relacionada &#224; hipertens&#227;o em crian&#231;as obesas<sup>20</sup>, tr&#234;s poss&#237;veis mecanismos foram discutidos: desequil&#237;brio da fun&#231;&#227;o auton&#244;mica (hiperatividade do sistema nervoso simp&#225;tico e/ou desequil&#237;brio entre o sistema nervoso simp&#225;tico e o parassimp&#225;tico); resist&#234;ncia &#224; insulina; e anormalidades na estrutura e fun&#231;&#227;o vascular (diminui&#231;&#227;o da complac&#234;ncia vascular). Possivelmente, a intera&#231;&#227;o entre esses diferentes mecanismos poderia resultar em hipertens&#227;o em crian&#231;as e adolescentes obesos. Dessa forma, como demonstrado no estudo realizado no Rio de Janeiro, o n&#237;vel de PA inicial &#233; um marco de agrega&#231;&#227;o familiar de fatores de risco cardiovasculares metab&#243;licos<sup>21</sup>. Muito embora o presente estudo n&#227;o tenha utilizado a obesidade central ou, especificamente, a massa gorda para classificar a popula&#231;&#227;o de crian&#231;as e adolescentes, a PA aumentou progressivamente com o aumento do percentil do IMC, refor&#231;ando a import&#226;ncia da rela&#231;&#227;o da obesidade ou aumento do IMC com a hipertens&#227;o. </p>
    <p>Podemos supor que o aumento da atividade simp&#225;tica, resist&#234;ncia &#224; insulina e anormalidades vasculares, citadas como mecanismos plaus&#237;veis para a hipertens&#227;o em indiv&#237;duos obesos, est&#225; relacionado ao aparecimento de agrupamentos de fatores de risco cardiovasculares, observados na s&#237;ndrome metab&#243;lica. Becque e cols.<sup>22</sup> avaliaram a incid&#234;ncia de fatores de risco para doen&#231;a arterial coronariana em adolescentes obesos e mostraram que 80% apresentavam hipertens&#227;o sist&#243;lica, hipertens&#227;o diast&#243;lica ou ambas. Tamb&#233;m demonstraram que 97% dessa popula&#231;&#227;o apresentava 4 ou mais fatores de risco agrupados (hipertrigliceridemia, HDL-colesterol baixo, hipercolesterolemia e hipertens&#227;o). Nossa popula&#231;&#227;o de crian&#231;as e adolescentes apresentava uma associa&#231;&#227;o significante de aumentos no PIMC com aumento da PA e tamb&#233;m com aumento de triglic&#233;rides e diminui&#231;&#227;o do HDL-colesterol. </p>
    <p>O HDL-colesterol &#233; um fator de prote&#231;&#227;o e apresenta uma rela&#231;&#227;o inversa com risco cardiovascular, como demonstrado por Barter e Rye<sup>23</sup>. Esses autores mostraram um aumento de 2 a 3% no risco cardiovascular para cada 1% de redu&#231;&#227;o nos n&#237;veis de HDL-colesterol. Eles tamb&#233;m mostraram que o perfil lip&#237;dico relacionado com a resist&#234;ncia &#224; insulina &#233; o baixo n&#237;vel de HDL-colesterol, frequentemente associado com a hipertrigliceridemia, e aumento das part&#237;culas de lipoprote&#237;na de baixa densidade (consideradas aterog&#234;nicas). De acordo com Weiss e cols.<sup>24</sup>, h&#225; uma associa&#231;&#227;o positiva entre a obesidade e a dislipidemia em crian&#231;as e adolescentes. Uma preval&#234;ncia de dislipidemia de at&#233; 50% foi encontrada em crian&#231;as com PIMC &gt; 99. Neste estudo, os autores usaram o excesso de peso para classificar o perfil lip&#237;dico. Um poss&#237;vel mecanismo para explicar essa associa&#231;&#227;o &#233; a ativa&#231;&#227;o da quinase dependente de AMPc que &#233; induzida pelo aumento nos n&#237;veis de insulina e leptina e pela redu&#231;&#227;o nos n&#237;veis de adiponectina. A adiponectina, isoladamente, aumenta a oxida&#231;&#227;o dos &#225;cidos graxos e tamb&#233;m apresenta uma associa&#231;&#227;o positiva com a sensibilidade &#224; insulina, HDL-colesterol e uma associa&#231;&#227;o negativa com os n&#237;veis de triglic&#233;rides. Por outro lado, a dislipidemia em beb&#234;s pode estar associada com a obesidade na vida adulta, especialmente em indiv&#237;duos do sexo feminino. A hiperinsulinemia &#233; indicada como um mecanismo causal comum para anormalidades metab&#243;licas, incluindo hipertrigliceridemia, baixo n&#237;vel de HDL-colesterol, aumento da PA e diabetes do tipo 2. Sinha e cols.<sup>25</sup> encontraram uma alta preval&#234;ncia de intoler&#226;ncia &#224; glicose em crian&#231;as obesas: 25% de 55 crian&#231;as obesas entre 4 10 anos de idade e em 21% de 112 adolescentes obesos entre 11 e 18 anos. Em nosso estudo, encontramos uma associa&#231;&#227;o positiva entre o aumento no PIMC e o aumento do &#237;ndice HOMA-ir, um &#237;ndice de resist&#234;ncia &#224; insulina que comumente aponta em dire&#231;&#227;o &#224; hiperinsulinemia e, consequentemente, &#224; hipertrigliceridemia, HDL-colesterol baixo e aumento na PA, tamb&#233;m encontrados no percentil mais alto de IMC de nossa popula&#231;&#227;o. </p>
    <p>Limita&#231;&#227;o do estudo: a popula&#231;&#227;o do estudo foi selecionada a partir de indiv&#237;duos que vieram &#224; clinica para serem submetidos &#224; um exame de sa&#250;de, n&#227;o sendo necessariamente uma amostra representativa da popula&#231;&#227;o geral da mesma faixa et&#225;ria. </p>
    <p>Em conclus&#227;o, este estudo caracterizou um perfil pr&#243;-ateroscler&#243;tico em crian&#231;as e adolescentes de acordo com excesso de peso, embora na aus&#234;ncia de sintomas cardiovasculares. </p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p>Os autores gostariam de agradecer ao Instituto do Cora&#231;&#227;o (InCor), Faculdade de Medicina da Universidade de S&#227;o Paulo, e aos Professores Jos&#233; Antonio Franchini Ramires e Eduardo Moacyr Krieger pela sua ajuda no desenvolvimento deste estudo. </p>
    <p>
      <bold>O que j&#225; &#233; conhecido sobre esse t&#243;pico: </bold>
    </p>
    <p>- Sabe-se que a gordura abdominal e o estilo de vida sedent&#225;rio est&#227;o relacionados &#224; resist&#234;ncia &#224; insulina. </p>
    <p>- Embora os crit&#233;rios diagn&#243;sticos da s&#237;ndrome metab&#243;lica j&#225; sejam conhecidos, estes s&#227;o confusos, mesmo para indiv&#237;duos adultos. Os melhores crit&#233;rios s&#227;o: circunfer&#234;ncia abdominal, IMC, raz&#227;o quadril/ circunfer&#234;ncia abdominal?</p>
    <p>- IMC e resist&#234;ncia &#224; insulina est&#227;o associados ao aumento do risco de DCV em adolescentes. </p>
    <p>
      <bold>O que este estudo acrescenta: </bold>
    </p>
    <p>- Que seja de nosso conhecimento, nenhum estudo havia analisado as caracter&#237;sticas da s&#237;ndrome metab&#243;lica em crian&#231;as e adolescentes, incluindo diferentes medidas antropom&#233;tricas. </p>
    <p>- Nossos dados foram analisados de acordo com os quartis, sugerindo um aumento no numero de caracter&#237;sticas da s&#237;ndrome metab&#243;lica de acordo com o aumento no percentil do IMC. </p>
    <p>- Todos os componentes da s&#237;ndrome metab&#243;lica mostraram a mesma tend&#234;ncia de acordo com o aumento nos percentis do IMC, demonstrando uma boa correla&#231;&#227;o desses componentes com o percentil do IMC. </p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de Doutorado de Geodete Batista Costa pelo Instituto do Cora&#231;&#227;o, Universidade Federal de Sergipe, Unidade Cardiotor&#225;cica de Sergipe.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Heno Ferreira Lopes </p>
        <p> Av. Dr. En&#233;as de C. Aguiar, 44, Bloco II, 2&#170; andar, sala 8, Cerqueira C&#233;sar </p>
        <p> 05403-000, S&#227;o Paulo, SP, Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="hipheno@incor.usp.br">hipheno@incor.usp.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido 20/08/08; revisado recebido 02/10/08; aceito em 21/10/08.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. World Health Organization. Global prevalence and secular trends in obesity-Preventing and managing the global epidemic. Consultation on obesity. Geneva: World Health Organization; 1998. p. 17-40.</mixed-citation>
        <element-citation publication-type="book">
          <source>Global prevalence and secular trends in obesity-Preventing and managing the global epidemic. Consultation on obesity</source>
          <date>
            <year>1998</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Despres JK. Obesity and lipoprotein metabolism.    New York: Marcel Dekker; 1997. p. 651-75.</mixed-citation>
        <element-citation publication-type="book">
          <source>Obesity and lipoprotein metabolism</source>
          <date>
            <year>1997</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Despres</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford    D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes    mellitus among adolescents. J Pediatr. 1996; 128: 608-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Increased incidence of non-insulin-dependent diabetes mellitus among adolescents</article-title>
          <source>J Pediatr</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>608</fpage>
          <lpage>15</lpage>
          <volume>128</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pinhas-Hamiel</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Dolan</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Standiford</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Khoury</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Zeitler</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Dietz WH. Health consequences of obesity in    youth: childhood predictors of adult disease. Pediatrics. 1998; 101: 518-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Health consequences of obesity in youth: childhood predictors of adult disease</article-title>
          <source>Pediatrics</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>518</fpage>
          <lpage>25</lpage>
          <volume>101</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dietz</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Story M, Evans M, Fabsitz RR, Clay TE, Holy    Rock B, Broussard B. The epidemic of obesity in American Indian communities    and the need for childhood obesity-prevention programs. Am J Clin Nutr. 1999;    69: 747S-754S.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The epidemic of obesity in American Indian communities and the need for childhood obesity-prevention programs</article-title>
          <source>Am J Clin Nutr</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>747S</fpage>
          <lpage>754S</lpage>
          <volume>69</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Story</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fabsitz</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Clay</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Holy Rock</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Broussard</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Tanner JM. Normal growth and techniques of    growth assessment. Clin Endocrinol Metab. 1986; 15: 411-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Normal growth and techniques of growth assessment</article-title>
          <source>Clin Endocrinol Metab</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>411</fpage>
          <lpage>51</lpage>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tanner</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. National Center for Health Statistics, NCHS Growth curves for childrenbirth - 18 years. United States: Vital and Health Statistics; 1989.</mixed-citation>
        <element-citation publication-type="book">
          <source>NCHS Growth curves for childrenbirth - 18 years</source>
          <date>
            <year>1989</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Update on the 1987 Task Force Report on High    Blood Pressure in Children and Adolescents: a working group report from the    National High Blood Pressure Education Program. National High Blood Pressure    Education Program Working Group on Hypertension Control in Children and Adolescents.    Pediatrics. 1996; 98: 649-58.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program</article-title>
          <source>Pediatrics</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>649</fpage>
          <lpage>58</lpage>
          <volume>98</volume>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Moriguchi E. Novos fatores de risco na pr&#225;tica    cl&#237;nica. Hipertens&#227;o. 2002; 5: 63-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Novos fatores de risco na pr&#225;tica cl&#237;nica</article-title>
          <source>Hipertens&#227;o</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>63</fpage>
          <lpage>6</lpage>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moriguchi</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Berenson GS, Srinivasan SR, Bao W, Newman    WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular    risk factors and atherosclerosis in children and young adults: the Bogalusa    Heart Study. N Engl J Med. 1998; 338: 1650-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1650</fpage>
          <lpage>6</lpage>
          <volume>338</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Newman 3rd</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Tracy</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Wattigney</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Nahoney LT, Burns TL, Stanford W, Thompson    BH, Witt JD, Rost CA, et al. Coronary risk factors measured in childhood and    young adult life are associated with coronary artery calcification in young    adults: the Muscatine Study. J Am Coll Cardiol. 1996; 27: 277-84.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>277</fpage>
          <lpage>84</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nahoney</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Stanford</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Witt</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Rost</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Relationship of atherosclerosis in young    men to serum lipoprotein cholesterol concentrations and smoking. A preliminary    report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)    Research Group. JAMA. 1990; 264: 3018-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking</article-title>
          <source>JAMA</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>3018</fpage>
          <lpage>24</lpage>
          <volume>264</volume>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Must A, Dallal GE, Dietz WH. Reference data    for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps    skinfold thickness. Am J Clin Nutr. 1991; 53: 839-46.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness</article-title>
          <source>Am J Clin Nutr</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>839</fpage>
          <lpage>46</lpage>
          <volume>53</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Must</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dallal</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Luukkaa V, Pesonen U, Huhtaniemi I, Lehtonen    A, Tilvis R, Tuomilehto J, et al. Inverse correlation between serum testosterone    and leptin in men. J Clin Endocrinol Metab. 1998; 83: 3243-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Inverse correlation between serum testosterone and leptin in men</article-title>
          <source>J Clin Endocrinol Metab</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>3243</fpage>
          <lpage>6</lpage>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Luukkaa</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pesonen</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Huhtaniemi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lehtonen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tilvis</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tuomilehto</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Ribeiro RQ, Lotufo PA, Lamounier JA, Oliveira    RG, Soares JF, Botter DA. Additional cardiovascular risk factors associated    with excess weight in children and adolescents: the Belo Horizonte heart study.    Arq Bras Cardiol. 2006; 86: 408-18.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Additional cardiovascular risk factors associated with excess weight in children and adolescents: the Belo Horizonte heart study</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>408</fpage>
          <lpage>18</lpage>
          <volume>86</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>RQ</given-names>
            </name>
            <name>
              <surname>Lotufo</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Lamounier</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Botter</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui    S. Contribution of intra-abdominal fat accumulation to the impairment of glucose    and lipid metabolism in human obesity. Metabolism. 1987; 36: 54-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity</article-title>
          <source>Metabolism</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>54</fpage>
          <lpage>9</lpage>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fujioka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Matsuzawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tarui</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Lapidus L, Bengtsson C, Hallstrom T, Bjorntorp    P. Obesity, adipose tissue distribution and health in women--results from a    population study in Gothenburg, Sweden. Appetite. 1989; 13: 25-35.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Obesity, adipose tissue distribution and health in women--results from a population study in Gothenburg, Sweden</article-title>
          <source>Appetite</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>25</fpage>
          <lpage>35</lpage>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lapidus</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bengtsson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hallstrom</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bjorntorp</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Daniels SR, Morrison JA, Sprecher DL, Khoury    P, Kimball TR. Association of body fat distribution and cardiovascular risk    factors in children and adolescents. Circulation. 1999; 99: 541-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association of body fat distribution and cardiovascular risk factors in children and adolescents</article-title>
          <source>Circulation</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>541</fpage>
          <lpage>5</lpage>
          <volume>99</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Daniels</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sprecher</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Khoury</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kimball</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Sorof J, Daniels S. Obesity hypertension    in children: a problem of epidemic proportions. Hypertension. 2002; 40: 441-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Obesity hypertension in children: a problem of epidemic proportions</article-title>
          <source>Hypertension</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>441</fpage>
          <lpage>7</lpage>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sorof</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Sociedade Brasileira de Cardiologia. I Diretriz    brasileira de preven&#231;&#227;o da aterosclerose in crian&#231;as e    adolescentes. Arq Bras Cardiol. 2005; 85 (supl 6): 4-36.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>I Diretriz brasileira de preven&#231;&#227;o da aterosclerose in crian&#231;as e adolescentes</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>4</fpage>
          <lpage>36</lpage>
          <volume>85</volume>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Magalhaes ME, Pozzan R, Brandao AA, Cerqueira    RC, Rousoulieres AL, Szwarcwald C, et al. Early blood pressure level as a mark    of familial aggregation of metabolic cardiovascular risk factors--the Rio de    Janeiro Study. J Hypertens. 1998; 16: 1885-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early blood pressure level as a mark of familial aggregation of metabolic cardiovascular risk factors--the Rio de Janeiro Study</article-title>
          <source>J Hypertens</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1885</fpage>
          <lpage>9</lpage>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Magalhaes</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brandao</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Cerqueira</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Rousoulieres</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Szwarcwald</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Becque MD, Katch VL, Rocchini AP, Marks CR,    Moorehead C. Coronary risk incidence of obese adolescents: reduction by exercise    plus diet intervention. Pediatrics. 1988; 81: 605-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention</article-title>
          <source>Pediatrics</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>605</fpage>
          <lpage>12</lpage>
          <volume>81</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Becque</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Katch</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Rocchini</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Moorehead</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Barter PJ, Rye KA. High density lipoproteins    and coronary heart disease. Atherosclerosis. 1996; 121: 1-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>High density lipoproteins and coronary heart disease</article-title>
          <source>Atherosclerosis</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1</fpage>
          <lpage>12</lpage>
          <volume>121</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Barter</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Rye</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Weiss R, Dziura J, Burgert TS, Tamborlane    WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children    and adolescents. N Engl J Med. 2004; 350: 2362-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Obesity and the metabolic syndrome in children and adolescents</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>2362</fpage>
          <lpage>74</lpage>
          <volume>350</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dziura</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Burgert</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Tamborlane</surname>
              <given-names>WV</given-names>
            </name>
            <name>
              <surname>Taksali</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Yeckel</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Sinha R, Fisch G, Teague B, Tamborlane WV,    Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children    and adolescents with marked obesity. N Engl J Med. 2002; 346: 802-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of impaired glucose tolerance among children and adolescents with marked obesity</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>802</fpage>
          <lpage>10</lpage>
          <volume>346</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sinha</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fisch</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Teague</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tamborlane</surname>
              <given-names>WV</given-names>
            </name>
            <name>
              <surname>Banyas</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">&#205;ndice de masa corporal presenta buena correlaci&#243;n con el perfil proateroscler&#243;tico en ni&#241;os y adolescentes</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: Recientemente, una asociaci&#243;n de diferentes factores de riesgo se describi&#243; como el s&#237;ndrome metab&#243;lico. Se est&#225;n utilizando diferentes definiciones para el mismo s&#237;ndrome. Independientemente del nombre o de la clasificaci&#243;n, se estableci&#243; que un agrupamiento de factores de riesgo cardiovascular, incluyendo sobrepeso/obesidad, aumento de la presi&#243;n arterial y anormalidades lip&#237;dicas y glic&#233;micas est&#225; asociado al aumento de riesgo de aterosclerosis en adultos. OBJETIVO: El objetivo de este estudio fue correlacionar los percentiles del &#237;ndice de masa corporal con la presi&#243;n arterial (PA), &#237;ndice de resistencia a la insulina (HOMA-ir) y perfiles lip&#237;dicos en ni&#241;os y adolescentes, los cuales caracterizan un perfil proateroscler&#243;tico. M&#201;TODOS: Se evaluaron agrupamientos de factores de riesgo cardiovascular en 118 ni&#241;os y adolescentes, divididos de acuerdo con los cuartiles del percentil de &#237;ndice de masa corporal (PIMC): Q1 (n=23) con PIMC &lt;50%, Q2 (n=30) con PIMC entre 50 y 85%, Q3 (n=31) con PIMC entre 85 y 93%, y Q4 (n=34) con PIMC &gt; 93%. Estad&#237;sticamente, no se observaron diferencias significativas para la edad (F=2,1; p=0,10); sexo (test Ji cuadrado=3,0; p=0,38), y origen &#233;tnico (test Ji cuadrado = 4,7; p=0,20) entre diferentes cuartiles. RESULTADOS: Una diferencia estad&#237;sticamente significativa se observ&#243; para PA sist&#243;lica (F=15,4; p&lt;0,0001), PA diast&#243;lica (F=9,5; p&lt;0,0001), glucemia (F=9,6; p&lt;0,0001), insulina (F=12.9; p&lt;0.0001), HOMA-ir (F=30,8; p&lt;0,0001), y niveles de triglic&#233;ridos (F=2,7; p=0,05) entre los diferentes cuartiles. CONCLUSI&#211;N: El exceso de peso evaluado por el PIMC se asoci&#243; al aumento de PA, triglic&#233;ridos, &#237;ndice HOMA-ir, y HDL - colesterol bajo, lo que configura un perfil proateroscler&#243;tico en ni&#241;os y adolescentes.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>&#205;ndice de masa corporal</kwd>
        <kwd>ni&#241;o</kwd>
        <kwd>adolescente</kwd>
        <kwd>factores de riesgo</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="tx-body2">
          <label>
            <bold>&#205;ndice de masa corporal presenta buena correlaci&#243;n con el perfil proateroscler&#243;tico en ni&#241;os y adolescentes</bold>
          </label>
          <p>
            <bold>Geodete Batista Costa<sup>II, III</sup>; Naira Horta<sup>III</sup>; Zulmira Freire Resende<sup>III</sup>; Graziela Souza<sup>III</sup>; Larissa Machado de Farias Barreto<sup>III</sup>; Luis Henrique Correia<sup>III</sup>; Thiago Augusto Nascimento<sup>III</sup>; Clay Barreto Rios<sup>III</sup>; Jos&#233; Augusto Barreto-Filho<sup>III</sup>; Heno Ferreira Lopes<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Instituto do Cora&#231;&#227;o (InCor), Faculdade de Medicina da Universidade de S&#227;o Paulo</p>
      <p><sup>II</sup>Hospital Escola da Universidade de Sergipe, Sergipe - Brasil</p>
      <p><sup>III</sup>Unidade Cardiotor&#225;cica de Sergipe; Sergipe - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> Recientemente, una asociaci&#243;n de diferentes factores de riesgo se describi&#243; como el s&#237;ndrome metab&#243;lico. Se est&#225;n utilizando diferentes definiciones para el mismo s&#237;ndrome. Independientemente del nombre o de la clasificaci&#243;n, se estableci&#243; que un agrupamiento de factores de riesgo cardiovascular, incluyendo sobrepeso/obesidad, aumento de la presi&#243;n arterial y anormalidades lip&#237;dicas y glic&#233;micas est&#225; asociado al aumento de riesgo de aterosclerosis en adultos.</p>
      <p><bold>OBJETIVO:</bold> El objetivo de este estudio fue correlacionar los percentiles del &#237;ndice de masa corporal con la presi&#243;n arterial (PA), &#237;ndice de resistencia a la insulina (HOMA-ir) y perfiles lip&#237;dicos en ni&#241;os y adolescentes, los cuales caracterizan un perfil proateroscler&#243;tico.</p>
      <p><bold>M&#201;TODOS:</bold> Se evaluaron agrupamientos de factores de riesgo cardiovascular en 118 ni&#241;os y adolescentes, divididos de acuerdo con los cuartiles del percentil de &#237;ndice de masa corporal (PIMC): Q1 (n=23) con PIMC &lt;50%, Q2 (n=30) con PIMC entre 50 y 85%, Q3 (n=31) con PIMC entre 85 y 93%, y Q4 (n=34) con PIMC &gt; 93%. Estad&#237;sticamente, no se observaron diferencias significativas para la edad (F=2,1; p=0,10); sexo (test Ji cuadrado=3,0; p=0,38), y origen &#233;tnico (test Ji cuadrado = 4,7; p=0,20) entre diferentes cuartiles.</p>
      <p><bold>RESULTADOS:</bold> Una diferencia estad&#237;sticamente significativa se observ&#243; para PA sist&#243;lica (F=15,4; p&lt;0,0001), PA diast&#243;lica (F=9,5; p&lt;0,0001), glucemia (F=9,6; p&lt;0,0001), insulina (F=12.9; p&lt;0.0001), HOMA-ir (F=30,8; p&lt;0,0001), y niveles de triglic&#233;ridos (F=2,7; p=0,05) entre los diferentes cuartiles.</p>
      <p><bold>CONCLUSI&#211;N:</bold> El exceso de peso evaluado por el PIMC se asoci&#243; al aumento de PA, triglic&#233;ridos, &#237;ndice HOMA-ir, y HDL &#150; colesterol bajo, lo que configura un perfil proateroscler&#243;tico en ni&#241;os y adolescentes.</p>
      <p><bold>Palabras clave: </bold> &#205;ndice de masa corporal, ni&#241;o, adolescente, factores de riesgo.</p>
      <p>
        <bold>Abreviaturas </bold>
      </p>
      <p>PIMC - percentil del &#237;ndice de masa corporal </p>
      <p>PA &#150; presi&#243;n arterial</p>
      <p>HDL &#150; lipoprote&#237;na de alta densidad</p>
      <p>HOMA-ir - Modelo de Evaluaci&#243;n de la Homeostasis de la resistencia a la insulina </p>
      <p>LDL &#150; lipoprote&#237;na de baja densidad </p>
      <p>SM &#150; s&#237;ndrome metab&#243;lico</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>De acuerdo con la Organizaci&#243;n Mundial de la Salud (OMS)<sup>1</sup>, la obesidad est&#225; adquiriendo proporciones epid&#233;micas en todo el mundo y es considerada una enfermedad pedi&#225;trica cr&#243;nica, m&#225;s peligrosa que la desnutrici&#243;n, por el hecho de estar asociada a un gran n&#250;mero de cofactores de morbilidad. Los problemas asociados con la obesidad incluyen problemas psicosociales (baja autoestima, afectando la capacidad acad&#233;mica y de relaci&#243;n), problemas sociales (preconcepto) y culminan con la asociaci&#243;n de obesidad central, resistencia a la insulina, hipertensi&#243;n y dislipidemia, que caracterizan un agrupamiento de factores de riesgo cardiovascular, tambi&#233;n llamados s&#237;ndrome metab&#243;lico (SM). El s&#237;ndrome metab&#243;lico est&#225; asociado a un aumento en la probabilidad de enfermedad ateroscler&#243;tica, esteatohepatitis y calculosis biliar, la cual est&#225; presente en individuos sedentarios con nutrici&#243;n exagerada y predisposici&#243;n gen&#233;tica<sup>2</sup>. </p>
      <p>La prevalencia de esta situaci&#243;n est&#225; aumentando en ni&#241;os y adolescentes, y la diabetes tipo 2 est&#225; apareciendo en esa poblaci&#243;n con mayor frecuencia<sup>3</sup>. Hay otras situaciones cl&#237;nicas asociadas con este agrupamiento de factores de riesgo cardiovascular que exigen atenci&#243;n: apnea del sue&#241;o asociada a hipertensi&#243;n pulmonar, hipertrofia del ventr&#237;culo izquierdo, pseudotumor cerebral y disturbios ortop&#233;dicos<sup>4</sup>. Evidencias cient&#237;ficas revelaron que la hipertensi&#243;n arterial y la aterosclerosis tienen inicio en la infancia, cuando se forman<sup>5</sup>. </p>
      <p>Este estudio describe el impacto del exceso de peso, evaluado mediante el percentil del &#237;ndice de masa corporal (PIMC) y proporciona los resultados de los niveles de PA, &#237;ndice de resistencia a la insulina y perfil lip&#237;dico en ni&#241;os y adolescentes considerados cl&#237;nicamente normales. </p>
      <p>Nuestra hip&#243;tesis es que el aumento en el PIMC resulta en una mayor probabilidad de agrupamiento de factores de riesgo cardiovascular, independiente de la edad y de las caracter&#237;sticas cl&#237;nicas. </p>
      <p>
        <bold>Pacientes</bold>
      </p>
      <p>Este es un estudio cl&#237;nico controlado (estudio anal&#237;tico transversal), que correlaciona el percentil del &#237;ndice de masa corporal (PIMC) con el perfil cardiovascular y bioqu&#237;mico en una poblaci&#243;n de ni&#241;os y adolescentes reclutados secuencialmente entre enero y noviembre de 2005 en cl&#237;nicas cardiopedi&#225;tricas, endocrinol&#243;gicas, centros ambulatorios y cl&#237;nicas particulares. Se incluy&#243; en el estudio un total de 118 individuos. &#201;stos se dividieron un cuartiles de acuerdo con el percentil del &#237;ndice de masa corporal (PIMC): Q1 (n = 23) con PIMC &lt;50%; Q2 (n=30) con PIMC entre 50 y 85%; Q3 (n=31) con PIMC entre 85 y 93%, y finalmente, Q4 (n=34) con PIMC &gt;93%. Las caracter&#237;sticas cl&#237;nicas de la poblaci&#243;n se muestran en la <xref ref-type="table" rid="tab01-body2">Tabla 1</xref>.</p>
      <table-wrap id="tab01-body2">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gt01-es.jpg"/></table-wrap>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Todas las medidas antropom&#233;tricas se realizaron al inicio de la ma&#241;ana y los voluntarios estaban en ayunas: a) El peso se midi&#243; en una balanza digital Tech Line, modelo Tec 10L (Techline Asia, China). Todos los individuos usaban ropa ligera, estaban descalzos y en posici&#243;n ortost&#225;tica. b) La altura se midi&#243; con estad&#237;metro fijado en posici&#243;n vertical. Los individuos se colocaron en posici&#243;n ortost&#225;tica, descalzos, con las piernas juntas y las nalgas y hombros en contacto con el eje vertical del estad&#237;metro. Los brazos se mantuvieron pr&#243;ximos al cuerpo y la medida se tom&#243; al final de la expiraci&#243;n. El peso y la altura se registraron de acuerdo con las curvas de Tanner<sup>6</sup>. c) Se calcul&#243; el &#205;ndice de Masa Corporal (IMC) o &#205;ndice Quetelet = peso (kg) dividido por el cuadrado de la altura (m<sup>2</sup>). Como &#233;sta es una poblaci&#243;n de ni&#241;os y adolescentes, el percentil para el IMC se us&#243; de acuerdo con el <italic>National Center for Health Statistics</italic><sup>7</sup> y se aplic&#243; para agruparlos en diferentes cuartiles.</p>
      <p> La presi&#243;n arterial (PA) se midi&#243; de acuerdo con el protocolo recomendado por el Update on the Task Force Report (1987) on <italic>High Blood Pressure in Children and Adolescents: A Working Group Report from the High Blood Pressure Education Program</italic><sup>8</sup>. Se utiliz&#243; un esfigmoman&#243;metro de mercurio calibrado, con manguito adecuado para medir la PA. Los individuos permanecieron en posici&#243;n sentada durante por lo menos 10 minutos en condiciones de descanso. La Fase I de Korotkoff se adopt&#243; para definir la presi&#243;n arterial sist&#243;lica y la Fase V de Korotkoff para presi&#243;n arterial diast&#243;lica. Hubo un intervalo de 2 minutos entre las medidas. Los individuos fueron instruidos a no ingerir caf&#233;, t&#233;, antiinflamatorios no esteroideos, corticosteroides y vasoconstrictores nasales por 12 horas antes de la medida de la presi&#243;n arterial. Se utiliz&#243; el promedio de tres medidas consecutivas. Para ambos sexos, la PA fue corregida de acuerdo con el percentil de la altura. </p>
      <p>Para el an&#225;lisis bioqu&#237;mico, se recogieron muestras de sangre despu&#233;s de un per&#237;odo de ayuno de 12 horas. El plasma fue separado y almacenado a -10&#176;C en un freezer. El nivel de triglic&#233;ridos se determin&#243; por el m&#233;todo enzim&#225;tico Trinder-reactivo Labtest &#150; colorim&#233;trico (kit comercial). El HDL &#150; colesterol se determin&#243; mediante el m&#233;todo COD-ANA Labtest Cat &#150; 60 (kit comercial). La glucemia en ayunas se determin&#243; por el m&#233;todo colorim&#233;trico enzim&#225;tico - Glucox 500/glucosa oxidasa (Selectra II, Brasil). La insulina se midi&#243; por el m&#233;todo de quimioluminiscencia, usando un equipo Immulite 2000 (DPC, EEUU). La glucemia en ayunas y la insulina se utilizaron para calcular el &#205;ndice del Modelo de Evaluaci&#243;n de la Homeostasis de la Resistencia a la Insulina (HOMA-ir) (glucosa mg/dl x insulina <italic>&#181;</italic>U/ml/22,5)9. Los padres o tutores de todos los pacientes incluidos en el estudio firmaron el t&#233;rmino de consentimiento libre e informado. El Comit&#233; de &#201;tica de la Universidad Federal de Sergipe, Brasil, aprob&#243; la investigaci&#243;n. </p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>En el an&#225;lisis estad&#237;stico se utiliz&#243; el software SPSS versi&#243;n 13.0 (SPSS, Chicago, IL). Datos no num&#233;ricos se resumieron en proporciones, con sus respectivos intervalos de confianza del 95%. Los datos num&#233;ricos se muestran en promedios y desviaciones est&#225;ndar. Variables nominales se muestran en frecuencias. La distribuci&#243;n normal se prob&#243; mediante el m&#233;todo de Shapiro-Wilkis. El an&#225;lisis de varianza (ANOVA) se utiliz&#243; para analizar la variaci&#243;n de las variables asociadas con el s&#237;ndrome metab&#243;lico de acuerdo con el percentil del &#237;ndice de masa corporal (PIMC). One-way ANOVA se utiliz&#243; para comparar diferentes cuartiles del PIMC; Bonferroni (varianza igual) y Tamhne (varianza diferente) se utilizaron como post tests. El an&#225;lisis de tendencia y la evaluaci&#243;n de tendencias lineales, c&#250;bicas y cuadr&#225;ticas para diferentes factores en cada cuartil se midieron por el m&#233;todo polinomial. El valor de P&lt;0,05 se adopt&#243; como estad&#237;sticamente significativo. </p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>La poblaci&#243;n no difiri&#243; en el promedio de edades (F=2,1; p=0,10); distribuci&#243;n de sexo (test Ji cuadrado =3,04; p=0,38), y origen &#233;tnico (test Ji cuadrado = 4,7; p=0,20) entre los diferentes cuartiles (<xref ref-type="table" rid="tab01-body2">Tabla 1</xref>). </p>
      <p>Hubo diferencia estad&#237;sticamente significativa con relaci&#243;n a la PA sist&#243;lica entre los diferentes cuartiles (F=15,4; p&lt;0,0001): Q4 versus Q1 (32,8+4,1; p&lt;0,0001); Q4 versus Q2 (23,0+4,0; p&lt;0,0001); Q3 versus Q1 (13,5+3,9; p=0,002); Q3 versus Q2 (12,2+4,0; p=0,02). No hubo diferencia entre Q1 y Q2 (<xref ref-type="fig" rid="fig01-body2">Figura 1</xref>). Una diferencia estad&#237;sticamente significativa se observ&#243; para la PA diast&#243;lica entre los cuartiles (F=9,5; p&lt;0,0001): Q4 versus Q1 (12,9+2,7; p&lt;0,01); Q4 versus Q2 (10,8+2,5; p&lt;0,0002) y Q4 versus Q3 (7,0+2,5; p=0,04) (<xref ref-type="fig" rid="fig02-body2">Figura 2</xref>). </p>
      <fig id="fig01-body2">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf01-es.jpg"/></fig>
      <fig id="fig02-body2">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf02-es.jpg"/></fig>
      <p>Con relaci&#243;n al metabolismo de carbohidratos, se observ&#243; una diferencia estad&#237;sticamente significativa entre los diferentes cuartiles para la glucemia (F=9,6; p&lt;0,0001); insulina (F=12,9; p&lt;0,0001), y HOMA-ir (F=30,8; p&lt;0,0001). Para la glucemia, se observ&#243; una diferencia entre los cuartiles: Q4 versus Q1 (12,2+2,6; p&lt;0,001); Q4 versus Q2 (10,3+2,4; p=0,0002), y Q4 versus Q3 (7,2+2,4; p=0,02) (<xref ref-type="fig" rid="fig03-body2">Figura 3</xref>).</p>
      <fig id="fig03-body2">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf03-es.jpg"/></fig>
      <p>Una diferencia estad&#237;sticamente significativa se observ&#243; para la insulina entre los cuartiles: Q4 versus Q1 (7,4+1,4; p&lt;0,0001); Q4 versus Q2 (6,9+1,4; p&lt;0,0001); Q3 versus Q1 (3,5+1,1; p=0,01), y Q3 versus Q2 (3,0+1,1; p=0,01) (<xref ref-type="fig" rid="fig04-body2">Figura 4</xref>). El &#237;ndice HOMA-ir difiri&#243; significativamente entre los cuartiles: Q4 versus Q1 (46,3+6,0; p&lt;0,0001); Q4 versus Q2 (45,6+6,0; p&lt;0,0001); Q4 versus Q3 (21,5+7,2; p=0,02); Q3 versus Q1 (24,8+3,9; p&lt;0,0001) y Q3 versus Q2 (24,2+3,9; p&lt;0,0001) (<xref ref-type="fig" rid="fig06-body2">Figura 5</xref>).</p>
      <fig id="fig04-body2">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf04-es.jpg"/></fig>
      <fig id="fig05-body2">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf05-es.jpg"/></fig>
      <p>Una diferencia estad&#237;sticamente significativa se observ&#243; en los perfiles lip&#237;dicos entre los cuartiles Q4 versus Q1 (38,6+13,3; p=0,03) para triglic&#233;ridos (F=2,7; p=0,05) (<xref ref-type="fig" rid="fig06-body2">Figura 6</xref>). Entre los cuartiles se observ&#243; una reducci&#243;n en los niveles de HDL &#150; colesterol; con todo, esta diferencia no fue estad&#237;sticamente significativa (F=1,9; p=0,14) (<xref ref-type="fig" rid="fig07-body2">Figura 7</xref>). Se ejecut&#243; un an&#225;lisis de tendencias y se observ&#243; un aumento lineal y significativo para la PA sist&#243;lica (F=39,3; p&lt;0,0001); PA diast&#243;lica (F=24,7; p&lt;0,0001); glucemia (F=26,5; p&lt;0,0001); insulina (F=32,5; p&lt;0,0001); triglic&#233;ridos (F=7,9; p=0,006), y HDL - colesterol (F=5,3; p=0,03), entre los cuartiles. Una tendencia tambi&#233;n se observ&#243; en la variaci&#243;n cuadr&#225;tica para el HOMA-ir (F=6,5; p=0,01), entre los cuartiles.</p>
      <fig id="fig06-body2">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf06-es.jpg"/></fig>
      <fig id="fig07-body2">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf07-es.jpg"/></fig>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>Hay varios estudios relacionados con factores de riesgo cardiovascular en adultos. No obstante, hay pocos estudios relacionados con el agrupamiento de factores de riesgo cardiovascular en ni&#241;os y adolescentes. Entre los estudios que ya evaluaron los factores de riesgo cardiovascular asociados en ni&#241;os y adolescentes, est&#225;n el Bogalusa Heart Study<sup>10</sup>, el Muscatine Study<sup>11</sup>, y el PDAY<sup>12</sup>. Estos estudios muestran la asociaci&#243;n entre m&#250;ltiples factores de riesgo y aterosclerosis en ni&#241;os y j&#243;venes adultos. En nuestro estudio, observamos la asociaci&#243;n entre el PIMC y un agrupamiento de factores de riesgo cardiovasculares, tales como aumento de la presi&#243;n arterial, HDL - colesterol bajo, aumento de los niveles de triglic&#233;ridos, aumento de los niveles de glucemia e insulina y aumento de la resistencia a la insulina evaluada a trav&#233;s del &#237;ndice HOMA-ir en ni&#241;os y adolescentes. Se sabe que este agrupamiento de factores de riesgo cardiovascular que aparece al inicio de la vida persistir&#225; y empeorar&#225; si la prevenci&#243;n primaria no se adopta precozmente. En consecuencia, este agrupamiento de factores de riesgo cardiovascular resultar&#225; en morbilidad y mortalidad cardiovascular en j&#243;venes adultos. La antropometr&#237;a se considera un m&#233;todo &#250;til para identificar exceso de peso, pues es un m&#233;todo accesible y aplicable universalmente. </p>
      <p>Los &#237;ndices antropom&#233;tricos se obtienen a partir de dos o m&#225;s combinaciones b&#225;sicas (peso, sexo, edad y altura)<sup>1</sup>. El IMC se calcula de acuerdo con el peso y la altura, y es ampliamente utilizado y aceptado para identificar individuos con sobrepeso y obesos. Pero el uso del IMC en ni&#241;os y adolescentes empez&#243; despu&#233;s del estudio de Must et al.<sup>13</sup>, el cual relat&#243; valores de referencia para percentiles de acuerdo con la edad y el sexto, y &#233;stos son considerados actualmente los valores de referencia por parte de la OMS. De acuerdo con este estudio, individuos con percentiles de IMC <underline>&gt;</underline>85 y &lt;95 son considerados como teniendo sobrepeso e individuos con percentiles de IMC <underline>&gt;</underline>95 se consideran obesos. Aunque el IMC haya sido usado para caracterizar la obesidad en ni&#241;os y adolescentes, &#233;ste presenta limitaciones. Una limitaci&#243;n indicada por Luukkaa et al.<sup>14</sup> es que el IMC no diferencia la masa magra de la masa grasa y no permite la separaci&#243;n de individuos con aumento de masa muscular, de aquellos con aumento de masa grasa. No obstante, aun el cuartil inferior (Q1) de la distribuci&#243;n de doblez cut&#225;neo subescapular, comparado con el cuartil superior (Q4), est&#225; relacionado con el aumento del riesgo de niveles elevados de colesterol total en ni&#241;os y adolescentes<sup>15</sup>. </p>
      <p>Actualmente, es importante conocer no s&#243;lo la masa magra, sino tambi&#233;n la distribuci&#243;n de grasa. Con relaci&#243;n a la distribuci&#243;n de grasa, Fujioka et al.<sup>16</sup> mostraron que la grasa abdominal est&#225; asociada con un alto riesgo de morbilidad y mortalidad, principalmente debido a la enfermedad cardiovascular. Lapidus et al.<sup>17</sup> demostraron que el aumento de la grasa abdominal est&#225; asociado con aumento de los niveles de insulina en el plasma (hiperinsulinemia) y este aumento es predictivo de hipertensi&#243;n y dislipidemia futuras. En otro estudio<sup>18</sup>, los autores concluyeron que la grasa abdominal es un importante predictor de un aumento de los niveles de triglic&#233;ridos, una disminuci&#243;n en los niveles de HDL-colesterol, y un aumento de la masa ventricular izquierda en ni&#241;os y adolescentes. </p>
      <p>Se sabe que la PA diast&#243;lica aumenta progresivamente a partir de 1 a&#241;o de edad hasta la adolescencia y que la PA diast&#243;lica aumenta despu&#233;s de los 5 &#243; 6 a&#241;os de edad, proporcionalmente a la PA sist&#243;lica. En ni&#241;os peque&#241;os, la hipertensi&#243;n secundaria es m&#225;s frecuente y despu&#233;s de los 10 a&#241;os de edad, principalmente en el adolescente, es la forma primaria de la hipertensi&#243;n la m&#225;s observada<sup>19</sup>. En una revisi&#243;n relacionada con la hipertensi&#243;n en ni&#241;os obesos<sup>20</sup>, se discutieron tres mecanismos posibles: desequilibrio de la funci&#243;n auton&#243;mica (hiperactividad del sistema nervioso simp&#225;tico y/o desequilibrio entre el sistema nerviosos simp&#225;tico y el parasimp&#225;tico); resistencia a la insulina; y anormalidades en la estructura y funci&#243;n vascular (disminuci&#243;n de la complacencia vascular). Posiblemente, la interacci&#243;n entre estos diferentes mecanismos podr&#237;a resultar en hipertensi&#243;n en ni&#241;os y adolescentes obesos. De esta forma, como se demuestra en el estudio realizado en R&#237;o de Janeiro, el nivel de PA inicial es un marco de agregaci&#243;n familiar de factores de riesgo cardiovascular metab&#243;licos<sup>21</sup>. A pesar de que el presente estudio haya utilizado la obesidad central, o espec&#237;ficamente la masa grasa para clasificar la poblaci&#243;n de ni&#241;os y adolescentes, la PA aument&#243; progresivamente con el aumento del percentil del IMC, reforzando la importancia de la relaci&#243;n de la obesidad o aumento del IMC con la hipertensi&#243;n. </p>
      <p>Podemos suponer que el aumento de la actividad simp&#225;tica, resistencia a insulina y anormalidades vasculares, citadas como mecanismos plausibles para la hipertensi&#243;n en individuos obesos, est&#225; relacionado con la aparici&#243;n de agrupamientos de factores de riesgo cardiovasculares, observados en el s&#237;ndrome metab&#243;lico. Becque et al.<sup>22</sup> evaluaron la incidencia de factores de riesgo para enfermedad arterial coronaria en adolescentes obesos y mostraron que el 80% presentaban hipertensi&#243;n sist&#243;lica, hipertensi&#243;n diast&#243;lica o ambas. Tambi&#233;n demostraban que el 97% de esta poblaci&#243;n presentaba 4 o m&#225;s factores de riesgo agrupados (hipertrigliceridemia, HDL-colesterol bajo, hipercolesterolemia e hipertensi&#243;n). Nuestra poblaci&#243;n de ni&#241;os y adolescentes presentaba una asociaci&#243;n significativa de aumentos en el PIMC con aumento de la PA y tambi&#233;n con aumento de triglic&#233;ridos y disminuci&#243;n del HDL-colesterol. </p>
      <p>El HDL-colesterol es un factor de protecci&#243;n y presenta una relaci&#243;n inversa con el riesgo cardiovascular, como lo demuestra Barter y Rye<sup>23</sup>. Estos autores mostraron un aumento del 2% al 3% en el riesgo cardiovascular para cada el 1% de reducci&#243;n en los niveles de HDL-colesterol. &#201;stos tambi&#233;n mostraron que el perfil lip&#237;dico relacionado con la resistencia a la insulina es el bajo nivel de HDL-colesterol, frecuentemente asociado a la hipertrigliceridemia, y aumento de las part&#237;culas de lipoprote&#237;na de baja densidad (consideradas aterog&#233;nicas). De acuerdo con Weiss et al.<sup>24</sup>, hay una asociaci&#243;n positiva entre la obesidad y la dislipidemia en ni&#241;os y adolescentes. Una prevalencia de dislipidemia de hasta el 50% se encontr&#243; en ni&#241;os con PIMC &gt; 99. En este estudio, los autores usaron el exceso de peso para clasificar el perfil lip&#237;dico. Un posible mecanismo para explicar esta asociaci&#243;n es la activaci&#243;n de la quinasa dependiente de AMPc que es inducida por el aumento en los niveles de insulina y leptina, y por la reducci&#243;n en los niveles de adiponectina. La adiponectina, aisladamente, aumenta la oxidaci&#243;n de los &#225;cidos grasos y tambi&#233;n presenta una asociaci&#243;n positiva con la sensibilidad a la insulina, HDL-colesterol y una asociaci&#243;n negativa con los niveles de triglic&#233;ridos. Por otro lado, la dislipidemia en beb&#233;s puede estar asociada con la obesidad en la vida adulta, especialmente en individuos del sexo femenino. La hiperinsulinemia se indica como un mecanismo causal com&#250;n para anormalidades metab&#243;licas, incluyendo hipertrigliceridemia, bajo nivel de HDL-colesterol, aumento de la PA y diabetes tipo 2. Sinha et al.<sup>25</sup> encontraron una alta prevalencia de intolerancia a la glucosa en ni&#241;os obesos: un 25% de 55 ni&#241;os obesos entre 4 y 10 a&#241;os de edad y en un 21% de 112 adolescentes obesos entre 11 y 18 a&#241;os. En nuestro estudio, encontramos una asociaci&#243;n positiva entre el aumento en el PIMC y el aumento del &#237;ndice HOMA-ir, un &#237;ndice de resistencia a la insulina que com&#250;nmente apunta en direcci&#243;n a la hiperinsulinemia, y consecuentemente a la hipertrigliceridemia, HDL-colesterol bajo y aumento en la PA, tambi&#233;n encontrados en el percentil m&#225;s alto de IMC de nuestra poblaci&#243;n. </p>
      <p>Limitaci&#243;n del estudio: la poblaci&#243;n del estudio se seleccion&#243; a partir de individuos que llegaron a la cl&#237;nica a ser sometidos a un examen de salud, no siendo necesariamente una muestra representativa de la poblaci&#243;n del mismo intervalo de edades. </p>
      <p>En conclusi&#243;n, este estudio caracteriz&#243; un perfil proateroscler&#243;tico en ni&#241;os y adolescentes de acuerdo con el exceso de peso, aunque en ausencia de s&#237;ntomas cardiovasculares. </p>
      <p>
        <bold>Agradecimientos</bold>
      </p>
      <p>Los autores quisieran agradecer al Instituto do Cora&#231;&#227;o (InCor), a la Facultad de Medicina de la Universidad de S&#227;o Paulo, y a los Profesores Jos&#233; Antonio Franchini Ramires y Eduardo Moacyr Krieger por su ayuda en el desarrollo de este estudio. </p>
      <p>Lo que ya es conocido sobre este tema: </p>
      <p>Se sabe que la grasa abdominal y el estilo de vida sedentario est&#225;n relacionados con la resistencia a la insulina.</p>
      <p>Aunque los criterios diagn&#243;sticos del s&#237;ndrome metab&#243;lico ya sean conocidos, &#233;stos son confusos, aun para individuos adultos. Los mejores criterios son: &#191;circunferencia abdominal, IMC, cociente cadera/circunferencia abdominal? IMC y resistencia a la insulina est&#225;n asociados al aumento del riesgo de ECV en adolescentes. </p>
      <p> Lo que agrega este estudio: </p>
      <p>Que sea de nuestro conocimiento, ning&#250;n estudio hab&#237;a analizado las caracter&#237;sticas del s&#237;ndrome metab&#243;lico en ni&#241;os y adolescentes, incluyendo diferentes medidas antropom&#233;tricas.</p>
      <p>Nuestros datos fueron analizados de acuerdo con los cuartiles, sugiriendo un aumento en el n&#250;mero de caracter&#237;sticas del s&#237;ndrome metab&#243;lico de acuerdo con el aumento en el percentil del IMC.</p>
      <p>Todos los componentes del s&#237;ndrome metab&#243;lico mostraron la misma deficiencia de acuerdo con el aumento en los percentiles del IMC, demostrando una buena correlaci&#243;n de esos componentes con el percentil del IMC. </p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiamiento</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiamiento externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de la tesis de Doctorado de Geodete Batista Costa del Instituto del Coraz&#243;n, Universidad Federal de Sergipe, Unidad Cardiotor&#225;cica de Sergipe.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Body mass index has a good correlation with proatherosclerotic profile in children and adolescents</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: More recently, the association of different risk factors has been described as the metabolic syndrome. Different definitions are being used for the same syndrome. Regardless of the name or classification, it has been well established that a cardiovascular cluster including overweight/obesity, increased blood pressure, and lipid and glucose abnormalities are associated with an increased risk of atherosclerosis in adults. OBJECTIVE: The aim of this study was to correlate body mass index percentiles with blood pressure, insulin resistance index, and lipid profiles in children and adolescents, which characterize a proatherosclerotic profile. METHODS: Cardiovascular risk factor clusters were evaluated in 118 children and adolescents divided according to body mass index percentile (BMIP) quartiles: Q1 (n=23) with BMIP &lt;50%, Q2 (n=30) with BMIP between 50 and 85%, Q3 (n=31) with BMIP between 85 and 93%, and Q4 (n=34) with the BMIP &gt; 93%. Statistically significant differences were not observed for age (F=2.1; p=0.10); sex (chi-square test=3.0; p=0.38), and ethnicity (chi-square test=4.7; p=0.20) between different quartiles. RESULTS: A statistically significant difference was observed for systolic BP (F=15.4; p&lt;0.0001), diastolic BP (F=9.5; p&lt;0.0001), glycemia (F=9.6; p&lt;0.0001), insulin (F=12.9; p&lt;0.0001), HOMAir (F=30.8; p&lt;0.0001), and triglyceride levels (F=2.7; p=0.05) between the different quartiles. CONCLUSION: Excess weight evaluated by BMIP was associated with increased blood pressure, triglycerides, HOMAir index, and low HDL-cholesterol, a proatherosclerotic profile in children and adolescents.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Body mass &#237;ndex</kwd>
        <kwd>child</kwd>
        <kwd>adolescent</kwd>
        <kwd>risk factors</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p><undefined id="tx-body3"/>Body mass index has a good correlation with proatherosclerotic profile in children and adolescents</p>
      <p>
        <bold>Geodete Batista Costa<sup>II, III</sup>; Naira Horta<sup>III</sup>; Zulmira Freire Resende<sup>III</sup>; Graziela Souza<sup>III</sup>; Larissa Machado de Farias Barreto<sup>III</sup>; Luis Henrique Correia<sup>III</sup>; Thiago Augusto Nascimento<sup>III</sup>; Clay Barreto Rios<sup>III</sup>; Jos&#233; Augusto Barreto-Filho<sup>III</sup>; Heno Ferreira Lopes<sup>I</sup></bold>
      </p>
      <p><sup>I</sup>Instituto do Cora&#231;&#227;o (InCor), Faculdade de Medicina da Universidade de S&#227;o Paulo</p>
      <p><sup>II</sup>Hospital Escola da Universidade de Sergipe, Sergipe, Brasil</p>
      <p><sup>III</sup>Unidade Cardiotor&#225;cica de Sergipe; Sergipe, Brasil</p>
      <p>Mailing address</p>
      <p>
        <bold>SUMMARY</bold>
      </p>
      <p><bold>BACKGROUND:</bold> More recently, the association of different risk factors has been described as the metabolic syndrome. Different definitions are being used for the same syndrome. Regardless of the name or classification, it has been well established that a cardiovascular cluster including overweight/obesity, increased blood pressure, and lipid and glucose abnormalities are associated with an increased risk of atherosclerosis in adults.</p>
      <p><bold>OBJECTIVE:</bold> The aim of this study was to correlate body mass index percentiles with blood pressure, insulin resistance index, and lipid profiles in children and adolescents, which characterize a proatherosclerotic profile.</p>
      <p><bold>METHODS:</bold> Cardiovascular risk factor clusters were evaluated in 118 children and adolescents divided according to body mass index percentile (BMIP) quartiles: Q1 (n=23) with BMIP &lt;50%, Q2 (n=30) with BMIP between 50 and 85%, Q3 (n=31) with BMIP between 85 and 93%, and Q4 (n=34) with the BMIP &gt; 93%. Statistically significant differences were not observed for age (F=2.1; p=0.10); sex (chi-square test=3.0; p=0.38), and ethnicity (chi-square test=4.7; p=0.20) between different quartiles.</p>
      <p><bold>RESULTS:</bold> A statistically significant difference was observed for systolic BP (F=15.4; p&lt;0.0001), diastolic BP (F=9.5; p&lt;0.0001), glycemia (F=9.6; p&lt;0.0001), insulin (F=12.9; p&lt;0.0001), HOMAir (F=30.8; p&lt;0.0001), and triglyceride levels (F=2.7; p=0.05) between the different quartiles.</p>
      <p><bold>CONCLUSION:</bold> Excess weight evaluated by BMIP was associated with increased blood pressure, triglycerides, HOMAir index, and low HDL-cholesterol, a proatherosclerotic profile in children and adolescents. </p>
      <p><bold>Key words:</bold> Body mass &#237;ndex; child; adolescent; risk factors.</p>
      <p>
        <bold>Abbreviations</bold>
      </p>
      <p>BMIP - body mass index percentile </p>
      <p>BP &#150; blood pressure</p>
      <p>HDL &#150; high-density lipoprotein</p>
      <p>HOMA-ir - homeostasis model assessment of insulin resistance </p>
      <p>LDL &#150; low-density lipoprotein</p>
      <p>MS &#150; metabolic syndrome</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>According to the World Health Organization<sup>1</sup>, obesity is assuming epidemic proportions all over the world and is considered a chronic pediatric disease, more dangerous than malnutrition, as it is associated with a large number of comorbidities. The problems associated with obesity include psychosocial problems (low self-esteem, affecting academic ability and relationships), social problems (prejudice), and culminate in the association of central obesity, insulin resistance, hypertension, and dyslipidemia, which characterize a cluster of cardiovascular risk factors also called metabolic syndrome (MS). Metabolic syndrome is associated with an increased chance of atherosclerotic disease, steatohepatitis, gallstones found in sedentary subjects with overnutrition and genetic predisposition<sup>2</sup>. The prevalence of this situation is increasing in children and adolescents, and type 2 diabetes is appearing in this population more frequently<sup>3</sup>. There are other clinical situations associated with this cardiovascular risk factor cluster that require attention: sleep apnea related to pulmonary hypertension, left ventricle hypertrophy, brain pseudotumor, and orthopedic disturbances<sup>4</sup>. Scientific evidence has revealed that high blood pressure and atherosclerosis begin in early childhood, when physical activity and food intake habits start<sup>5</sup>. </p>
      <p>This study describes the impact of excess weight, evaluated by body mass index percentile, and provides the results of blood pressure levels, insulin resistance index, and lipid profile in children and adolescents considered to be clinically normal. </p>
      <p>Our hypothesis is that the increase in the body mass index percentile will result in a higher probability of clustering of cardiovascular risk factors, regardless of age and clinical features.</p>
      <p>
        <bold>Patients</bold>
      </p>
      <p>This is a clinical controlled trial (transversal analytic study) that correlates the body mass index percentile (BMIP) with the cardiovascular and biochemical profile in a population of children and adolescents recruited sequentially between January and November 2005 from cardio-pediatric, endocrinology outpatient centers and private offices. A total of 118 subjects was included in the study. They were divided into quartiles according to their body mass index percentile: Q1 (n = 23) with BMIP &lt;50%; Q2 (n=30) with BMIP between 50 and 85%; Q3 (n=31) with BMIP between 85 and 93%, and finally Q4 (n=34) with BMIP &gt;93%. Clinical characteristics of the population are shown in <xref ref-type="table" rid="tab01-body3">Table 1</xref>.</p>
      <table-wrap id="tab01-body3">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gt01-en.jpg"/></table-wrap>
      <p>
        <bold>Methods</bold>
      </p>
      <p>All the anthropometric measurements were performed early in the morning, and the volunteers were fasting: a) Weight was measured with a digital Tech Line scale, model Tec 10L (Techline Asia, China). All the subjects wore light clothing, were barefoot, and were in an orthostatic position. b) Height was measured in a stadiometer fixed in the vertical position. Subjects were in the orthostatic position, barefoot, with feet together and bottom and shoulders touching the vertical axis of the stadiometer. They kept the arms close to the body, and the measurement was taken at the end of expiration. Weight and height were registered according to Tanner<sup>6</sup> curves. c) Body mass index (BMI) or Quetelet index = weight (kg) divided by height (m<sup>2</sup>) was calculated. Because this was a population of children and adolescents, the BMI percentile was used according to the National Center for Health Statistics<sup>7 </sup>and applied to divide them into different quartiles. </p>
      <p>Blood pressure (BP) was measured according to the protocol recommended by the Update on the Task Force Report (1987) on High Blood Pressure in Children and Adolescents: A Working Group Report from the High Blood Pressure Education Program<sup>8</sup>. A calibrated mercury sphygmomanometer with appropriate-sized cuff was used. Subjects were in a sitting position for at least 10 minutes in a resting condition. Phase I of Korotkoff was adopted to define the systolic blood pressure and phase V of Korotkoff for diastolic blood pressure. There was a 2-minute interval between the measurements. Subjects were instructed not to take coffee, tea, nonsteroidal anti-inflammatory drugs, corticosteroids, or nasal vasoconstrictors for 12 hours before the blood pressure measurements. The mean of 3 consecutive measures was used. For both sexes, blood pressure was corrected according to height percentile. </p>
      <p> For the biochemical evaluation, blood samples were drawn after a 12-hour fasting period. Blood plasma was separated and stored at -10&#176;C in a freezer. Triglycerides were measured using the enzymatic Trinder-reagent Lab test &#150; colorimetric method (commercial kit). HDL-cholesterol was measured with the COD-ANA Labtest Cat &#150; 60 method (commercial kit). Fasting blood glucose was measured by the enzymatic colorimetric - Glucox 500/glucose oxidase (Selectra II, Brazil). Insulin was measured by the chemilumminescence method using an Immulite 2000 machine (DPC, USA). Fasting glucose and insulin were used to calculate the homeostasis model of assessment of insulin resistance (HOMA-ir) (glucose mg/dL x insulin <italic>&#181;</italic>U/mL/22.5)<sup>9</sup>. The parents or a legal representative of all study patients signed a written informed consent. The Ethics Committee of the Federal University of Sergipe, Brazil, approved this research.</p>
      <p>
        <bold>Statistical analysis </bold>
      </p>
      <p>The SPSS package version 13.0 (SPSS, Chicago, IL) was used for the statistical analysis. Non-numeric data are summarized in proportions, with the respective confidence intervals of 95%. Numeric data are shown as means and standard deviations. Nominal variables are shown as frequencies. The normal distribution was tested by the Shapiro-Wilks test. Analysis of variance (ANOVA) was used to analyze the variation of variables associated with metabolic syndrome according to body mass index percentile. One-way ANOVA was used to compare different quartiles of the body mass index percentile; Bonferroni (equal variance) and Tamhne (different variance) were used as posttests. The trend analysis and evaluation for linear, cubic, and quadratic trends for different factors in each quartile was measured by the polynomial method. P&lt;0.05 was adopted as statistically significant. </p>
      <p>
        <bold>Results</bold>
      </p>
      <p>The population did not differ regarding mean age (F=2.1; p=0.10); sex distribution (chi-square test=3.04; p=0.38), and ethnicity (chi-square test=4.7; p=0.20) between the different quartiles (<xref ref-type="table" rid="tab01-body3">Table 1</xref>). </p>
      <p>There was a statistically significant difference for systolic BP between different quartiles (F=15.4; p&lt;0.0001): Q4 <italic>versus</italic> Q1 (32.8&#177;4.1; p&lt;0.0001); Q4 <italic>versus</italic> Q2 (23.0&#177;4.0; p&lt;0.0001); Q3 <italic>versus</italic> Q1 (13.5&#177;3.9; p=0.002); Q3 <italic>versus</italic> Q2 (12.2&#177;4.0; p=0.02). There was no difference between Q1 and Q2 (<xref ref-type="fig" rid="fig01-body3">Figure 1</xref>). A statistically significant difference was observed for diastolic BP between quartiles (F=9.5; p&lt;0.0001): Q4 <italic>versus</italic> Q1 (12.9&#177;2.7; p&lt;0.01); Q4 <italic>versus</italic> Q2 (10.8&#177;2.5; p&lt;0.0002) and Q4 <italic>versus</italic> Q3 (7.0&#177;2.5; p=0.04) (<xref ref-type="fig" rid="fig02-body3">Figure 2</xref>).</p>
      <fig id="fig01-body3">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf01-en.jpg"/></fig>
      <fig id="fig02-body3">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf02-en.jpg"/></fig>
      <p>Regarding carbohydrate metabolism, a statistically significant difference was observed between the different quartiles for glycemia (F=9.6; p&lt;0.0001); insulin (F=12.9; p&lt;0.0001), and HOMA-ir (F=30.8; p&lt;0.0001). For glycemia, a difference was observed between quartiles: Q4 <italic>versus</italic> Q1 (12.2&#177;2.6; p&lt;0.001); Q4 <italic>versus</italic> Q2 (10.3&#177;2.4; p=0.0002), and Q4 <italic>versus</italic> Q3 (7.2&#177;2.4; p=0.02) (<xref ref-type="fig" rid="fig03-body3">Figure 3</xref>). A statistically significant difference was observed for insulin between quartiles: Q4 <italic>versus</italic> Q1 (7.4&#177;1.4; p&lt;0.0001); Q4 <italic>versus</italic> Q2 (6.9&#177;1.4; p&lt;0.0001); Q3 <italic>versus</italic> Q1 (3.5&#177;1.1; p=0.01), and Q3 <italic>versus</italic> Q2 (3.0&#177;1.1; p=0.01) (<xref ref-type="fig" rid="fig04-body3">Figure 4</xref>). HOMA-ir differed significantly between quartiles: Q4 <italic>versus</italic> Q1 (46.3&#177;6.0; p&lt;0.0001); Q4 <italic>versus</italic> Q2 (45.6&#177;6.0; p&lt;0.0001); Q4 <italic>versus</italic> Q3 (21.5&#177;7.2; p=0.02); Q3 <italic>versus</italic> Q1 (24.8&#177;3.9; p&lt;0.0001) and Q3 <italic>versus</italic> Q2 (24.2&#177;3.9; p&lt;0.0001) (<xref ref-type="fig" rid="fig05-body3">Figure 5</xref>).</p>
      <fig id="fig03-body3">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf03-en.jpg"/></fig>
      <fig id="fig04-body3">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf04-en.jpg"/></fig>
      <fig id="fig05-body3">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf05-en.jpg"/></fig>
      <p>A statistically significant difference was observed for lipid profiles between the quartiles: Q4 <italic>versus</italic> Q1 (38.6&#177;13.3; p=0.03) and for triglycerides (F=2.7; p=0.05) (<xref ref-type="fig" rid="fig06-body3">Figure 6</xref>). A reduction in HDL-cholesterol levels was observed between quartiles; however, the difference was not statistically significant (F=1.9; p=0.14) (<xref ref-type="fig" rid="fig07-body3">Figure 7</xref>). </p>
      <fig id="fig06-body3">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf06-en.jpg"/></fig>
      <fig id="fig07-body3">
        <graphic xlink:href="1678-4170-abc-93-03-0261-00010-gf07-en.jpg"/></fig>
      <p>An analysis for trends was performed and a linear and significant increase was observed for systolic BP (F=39.3; p&lt;0.0001); diastolic blood pressure (F=24.7; p&lt;0.0001); glycemia (F=26.5; p&lt;0.0001); insulin (F=32.5; p&lt;0.0001); triglycerides (F=7.9; p=0.006), and HDL-cholesterol (F=5.3; p=0.03), between the quartiles. A trend was also observed in the quadratic variation for HOMA-ir (F=6.5; p=0.01), between the quartiles.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>There have been several studies related to cardiovascular risk factors in adults. However, few studies have been related to the cluster of cardiovascular risk factors in children and adolescents. Among the studies that have addressed the associated cardiovascular risk factors in children and adolescents are the Bogalusa Heart Study<sup>10</sup>, the Muscatine Study<sup>11</sup>, and the PDAY<sup>12</sup>. These studies have shown the association between multiple risk factors and atherosclerosis in children and young adults. In our study, we observed the association between the body mass index percentile and a cluster of cardiovascular risk factors, such as increased blood pressure, low HDL-cholesterol, increased triglyceride levels, increase in glucose and insulin levels, as well as insulin resistance, evaluated by the HOMA-ir index in children and adolescents. It is well known that this cluster of cardiovascular risk factors that appear early in life will persist and worsen if primary prevention is not precociously adopted. Consequently, this cluster of cardiovascular risk factors will result in cardiovascular morbidity and mortality in young adults.</p>
      <p>Anthropometry is considered a useful method to track excess weight, as it is not expensive and is universally applicable. The anthropometric indexes are obtained from 2 or more basic combinations (weight, sex, age, and height)<sup>1</sup>. Body mass index is calculated according to weight and height and is largely used and accepted to identify overweight and obese subjects. But the use of BMI in children and adolescents started after the study by Must et al<sup>13</sup>, which reported reference values for percentiles according to age and sex, and those are currently considered as reference values by the World Health Organization. According to this study, subjects with BMI percentiles <underline>&gt;</underline>85 and &lt;95 are considered overweight, and subjects with BMI percentile <underline>&gt;</underline>95 are considered obese. Although body mass index has been used to characterize obesity in children and adolescence, it has limitations. One limitation pointed out by Luukkaa et al<sup>14 </sup>is that BMI does not discriminate lean mass from fat mass, and does not permit the separation of subjects with increased muscle mass from those with increased fat mass. However, even the low quartile (Q1) of the distribution of subscapular skinfold, when compared to upper quartile (Q4) is related to increased risk of elevated total cholesterol (TC) levels in children and adolescents<sup>15</sup>. Currently, it is important to know not just the fat mass, but also the fat distribution. Regarding the fat distribution, Fujioka et al<sup>16</sup> showed that abdominal fat is associated with a high risk of morbidity and mortality, mainly from cardiovascular disease. Lapidus et al<sup>17</sup> demonstrated that increased abdominal fat is associated with increased plasma insulin levels (hyperinsulinemia), and increased plasma insulin levels are predictive of future hypertension and dyslipidemia. In another study<sup>18</sup>, the authors concluded that abdominal fat is an important predictor of an increase in triglycerides, a decrease in HDL-cholesterol, and an increase in left ventricular mass in children and adolescents. It is well known that systolic BP increases progressively from 1 year of age until adolescence and that diastolic BP increases after 5 to 6 years of age, proportionally to systolic BP. In young children, secondary hypertension is more frequent, and after 10 years of age, mainly in adolescents, the primary form of hypertension is more often observed<sup>19</sup>. In a review related to hypertension in obese children<sup>20</sup>, 3 possible mechanisms have been discussed: autonomic function imbalance (hyperactivity of the sympathetic nervous system and/or an imbalance between the sympathetic and the parasympathetic nervous systems); insulin resistance; and abnormalities in vascular structure and function (decrease in vascular compliance). Possibly, the interaction among these different mechanisms might result in hypertension in obese children and adolescents. Therefore, as demonstrated in the Rio de Janeiro study, early blood pressure level is a mark of familial aggregation of metabolic cardiovascular risk factors<sup>21</sup>. Even though the present study did not use central obesity or specifically the fat mass to classify the population of children and adolescents, blood pressure increased progressively with the increase in the body mass index percentile, strengthening the importance of the relation between obesity or the increase in body mass and hypertension. We can speculate that increased sympathetic activity, insulin resistance, and vascular abnormalities, cited as plausible mechanisms for hypertension in obese people, are related to the appearance of cardiovascular risk factor clusters, observed in the metabolic syndrome.</p>
      <p>Becque et al<sup>22</sup> evaluated the incidence of risk factors for coronary artery disease in obese adolescents and showed that 80% had systolic hypertension, diastolic hypertension, or both. They also showed that 97% of this population had 4 or more clustered risk factors (hypertriglyceridemia, low HDL-cholesterol, hypercholesterolemia, and hypertension). Our population of children and adolescents had a significant association of increase in body mass index percentile with increased blood pressure and also with increased triglycerides, and decreased HDL-cholesterol. The HDL-cholesterol is a protective factor and has an inverse relation to cardiovascular risk as shown by Barter and Rye<sup>23</sup>. These authors showed an increase in 2 to 3% in cardiovascular risk for each 1% reduction in HDL-cholesterol level. They also showed that the lipid profile related to insulin resistance is low HDL-cholesterol, frequently associated with hypertriglyceridemia and increased low-density LDL-cholesterol particles (considered atherogenic). According to Weiss et al<sup>24</sup>, there is a positive association between obesity and dyslipidemia in children and adolescents. A prevalence of dyslipidemia of up to 50% was found in children with body mass index percentile over 99. In this study, the authors used excess weight to classify the lipid profile. One possible mechanism to explain this association is the activation of AMP-dependent kinase that is induced by the increase in insulin and leptin and the reduction in adiponectin levels. Adiponectin, alone, increases fatty acid oxidation. Adiponectin also has a positive association with insulin sensitivity, HDL-cholesterol, and a negative association with triglyceride levels. On the other hand, dyslipidemia in infants can be associated with obesity in adult life, especially in females. Hyperinsulinemia is indicated as a possible common causal mechanism for metabolic abnormalities, including hypertriglyceridemia, low HDL-cholesterol, increased blood pressure, and type 2 diabetes. Sinha et al<sup>25</sup> found a high prevalence of glucose intolerance in obese children: 25% of 55 obese children between 4 and 10 years old and in 21% of 112 obese adolescents between 11 and 18 years old. In our study, we found a positive association between the increase in the body mass index percentile and increase in HOMA-ir, an insulin resistance index that commonly points toward hyperinsulinemia and consequently to hypertriglyceridemia, low HDL-cholesterol, and increased blood pressure, also found in the highest body mass index percentile in our population. Study limitation: the study population was selected among subjects who came to the clinic for medical check-ups and therefore, it is not necessarily a representative sample of the general population of the same age group.</p>
      <p>In conclusion, this study characterized a proatherosclerotic profile in children and adolescents according to excess weight, although in the absence of cardiovascular symptoms. </p>
      <p>
        <bold>Acknowledgments</bold>
      </p>
      <p>The authors would like to thank the Heart Institute (InCor), University of S&#227;o Paulo Medical School, Prof. Jos&#233; Antonio Franchini Ramires and Prof. Eduardo Moacyr Krieger for their support in developing this study. </p>
      <p>
        <bold>What is already known about this topic:</bold>
      </p>
      <p>- It is already known that abdominal fat and sedentary lifestyle are related to insulin resistance.</p>
      <p>- Although diagnostic criteria for metabolic syndrome are already known, they are unclear even for adults. The best criteria are: Abdominal circumference, BMI, hip/abdominal circumference ratio?</p>
      <p>- BMI and insulin resistance are associated with increased CVD risk in adolescents. </p>
      <p>
        <bold>What this study adds:</bold>
      </p>
      <p>- To the best of our knowledge, no study had analyzed the metabolic syndrome features in children and adolescents, including different anthropometric measurements.</p>
      <p>- Our data were analyzed according to quartiles, suggesting an increase in the number of metabolic syndrome features according to the increase in BMI percentile. </p>
      <p>- All metabolic syndrome components showed the same tendency according to the increase in the BMI percentiles, showing a good correlation between these components and the BMI percentile. </p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of Doctoral submitted by Geodete Batista Costa, from Instituto do Cora&#231;&#227;o, Universidade Federal de Sergipe, Unidade Cardiotor&#225;cica de Sergipe.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
